Navigation Links
NIAID and Chinese officials sign agreement to foster TB research in China's Henan province
Date:4/28/2009

Officials from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and from China's Henan Provincial Bureau of Health will meet in Zhengzhou, China, on April 29 to sign an implementation arrangement intended to foster research on tuberculosis, including clinical research on new treatments for multidrug-resistant tuberculosis (MDR TB). The Henan Provincial Bureau of Health and the NIAID plan to develop jointly a collaborative TB research program at the Henan Provincial Chest Hospital.

"The emergence of drug-resistant strains of tuberculosis in China and elsewhere around the world is deeply concerning to public health officials everywhere," says NIAID Director Anthony S. Fauci, M.D. "The implementation arrangement is an important step toward what we expect will be a fruitful collaboration between U.S. and Chinese investigators. It also confirms our shared commitment to finding new ways to lessen the burden of tuberculosis."

NIAID Principal Deputy Director Hugh Auchincloss, M.D., will attend the signing ceremony. "The new initiative linking Chinese and U.S. investigators in the battle against TB is most welcome, especially in light of the recent call by the World Health Organization for expanded international research to combat this devastating disease," Dr. Auchincloss says.

According to the latest available figures from WHO, about 1.3 million people in China developed active TB disease in 2007. Researchers at the new center will carry out several projects, including clinical trials of new drugs or drug combinations designed to treat MDR TB and extensively drug-resistant TB (XDR TB). The WHO estimates that about 5 percent of newly diagnosed TB cases in China are multidrug-resistant, while 26 percent of previously but incompletely treated TB cases are multidrug-resistant. Drug-sensitive strains of TB usually can be treated successfully with a combination of antibiotics, but the lack of potent and affordable second-line TB drugs makes treating MDR and XDR TB extremely difficult. In addition to research leading to new MDR and XDR TB treatment approaches, the investigators also expect to work together to develop improved methods for rapid and accurate diagnosis of drug-sensitive and drug-resistant TB.


'/>"/>

Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Related medicine news :

1. NIAID funds $51M contract to create comprehensive model of immune responses
2. NIAID strengthens and expands Vaccine and Treatment Evaluation Units
3. NIAID scientists identify new cellular receptor for HIV
4. NIAID to convene HIV Vaccine Summit
5. NIAID describes research priorities to fight drug-resistant tuberculosis
6. NIAID to advance B-cell approach to HIV vaccines
7. NIAID creates HIV vaccine discovery branch
8. NIAID awards contracts to search for protein markers of disease
9. NIAID media availability: Seizures following parasitic infection associated with brain swelling
10. NIAID honors AIDS activist Martin Delaney
11. High alcohol consumption increases stroke risk among Chinese men
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2016)... ... April 30, 2016 , ... Create ... Abstract users can distort and manipulate three-dimensional shapes with ease all within ... ranks, point, lines, polygons, polygon texture animation, opacity texture animation, overall shape texture ...
(Date:4/30/2016)... , ... April 30, 2016 ... ... CBC News on April 4th, 2016 questioned the use of the HyProCure ... EOTTS-HyProCure as “a controversial procedure.” EOTTS-HyProCure is a minimally invasive procedure performed, ...
(Date:4/29/2016)... ... April 29, 2016 , ... In an article published April ... enthusiasm for Botox and lip injections, which she underwent in order to feel more ... Music and Arts Festival. The article explains that Ms. Mirmelli’s situation is not unique; ...
(Date:4/29/2016)... ... April 29, 2016 , ... On Tuesday, April 26, 2016 members of the ... signature of Gov. Nathan Deal on SB 258, the “Rural Health Care Relief” Bill. ... a 70% tax credit to individuals and corporations which donate directly to a “rural ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... Coast Dental ... 16, 2016, at its new location in the Exchange Furniture Mall at 112 Vilseck ... for a 50-inch Samsung Smart TV. Plus attendees will have the opportunity to meet ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... 2016 Automation is one of ... to the growing demands for productivity in speed, accuracy, ... systems are already adept of a wide range of ... manual labor. Instrumentation continues to evolve, and is poised ... a few years ago. Originally used mostly by the ...
(Date:4/28/2016)... April 28, 2016  While Abbott,s announced purchase ... company,s valve repair and stent business, healthcare research ... Abbott more firmly into patient monitoring.  Kalorama said ... growing device areas, with double-digit growth expected the ... Advanced Remote Patient Monitoring . Abbott ...
(Date:4/28/2016)... April 28, 2016  Marking its one year ... and ovarian cancer risk test, Color Genomics ... genes that highly impact the most common hereditary ... the Color Test analyzes hereditary cancer risks for ... uterine cancers. The Color Test is physician ordered ...
Breaking Medicine Technology: